Posted by Xavier Holt on Oct 9th, 2021
Tigress Financial reaffirmed their buy rating on shares of USANA Health Sciences (NYSE:USNA) in a report published on Friday morning, TipRanks reports. The brokerage currently has a $122.00 target price on the stock.
Separately, Zacks Investment Research upgraded shares of USANA Health Sciences from a sell rating to a hold rating in a research report on Wednesday, September 29th.
Shares of USNA stock traded down $0.57 on Friday, reaching $95.71. The stock had a trading volume of 68,223 shares, compared to its average volume of 89,507. USANA Health Sciences has a 12 month low of $73.00 and a 12 month high of $107.85. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 14.44 and a beta of 0.85. The firm’s 50-day moving average is $94.39 and its two-hundred day moving average is $98.16.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, July 27th. The company reported $1.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.78 by $0.09. USANA Health Sciences had a return on equity of 33.65% and a net margin of 11.09%. The company had revenue of $336.84 million during the quarter, compared to the consensus estimate of $340.20 million. Research analysts forecast that USANA Health Sciences will post 6.31 earnings per share for the current year.
In other news, Director John Turman Fleming sold 300 shares of USANA Health Sciences stock in a transaction on Monday, August 30th. The stock was sold at an average price of $97.26, for a total value of $29,178.00. Following the transaction, the director now owns 851 shares in the company, valued at approximately $82,768.26. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Robert A. Sinnott sold 1,648 shares of the firm’s stock in a transaction dated Monday, August 16th. The shares were sold at an average price of $95.04, for a total value of $156,625.92. Following the completion of the sale, the insider now directly owns 1,648 shares in the company, valued at $156,625.92. The disclosure for this sale can be found here. Insiders have sold 3,435 shares of company stock worth $331,837 over the last quarter. Corporate insiders own 0.21% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in shares of USANA Health Sciences by 8.4% in the first quarter. Geode Capital Management LLC now owns 204,309 shares of the company’s stock valued at $19,940,000 after buying an additional 15,758 shares during the period. Quantbot Technologies LP raised its stake in shares of USANA Health Sciences by 378.8% during the first quarter. Quantbot Technologies LP now owns 3,835 shares of the company’s stock valued at $374,000 after acquiring an additional 3,034 shares during the last quarter. Swiss National Bank grew its stake in shares of USANA Health Sciences by 1.4% in the first quarter. Swiss National Bank now owns 28,900 shares of the company’s stock worth $2,821,000 after purchasing an additional 400 shares during the last quarter. QS Investors LLC increased its holdings in USANA Health Sciences by 35.1% in the first quarter. QS Investors LLC now owns 8,200 shares of the company’s stock valued at $801,000 after purchasing an additional 2,130 shares during the period. Finally, Prudential Financial Inc. raised its position in USANA Health Sciences by 11.9% during the 1st quarter. Prudential Financial Inc. now owns 132,840 shares of the company’s stock worth $12,965,000 after purchasing an additional 14,104 shares during the last quarter. Institutional investors own 54.77% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.
Featured Article: How can investors invest in the Euro STOXX 50 Index?
Receive News & Ratings for USANA Health Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for USANA Health Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.
You might be interested in: